In a bold stride towards next-generation protection against COVID-19, Moderna has officially announced FDA approval of its newest vaccine, mNexspike. Unlike earlier vaccines that followed a one-size-fits-all framework, mNexspike represents a carefully engineered evolution—delivering protection with a significantly lower dosage. This refined design is especially attuned to the needs of older adults and those living […]
Tag: Moderna
FDA Approves Next-Gen Covid Vaccine by Moderna
The FDA has granted approval for a next-generation Covid vaccine developed by Moderna, albeit with certain restrictions. Recent changes on the CDC’s website reflect a shift in recommendations for pregnant individuals regarding Covid vaccination. While pregnant people are no longer advised to receive the vaccine, the agency continues to stress the importance of Covid boosters […]
Moderna Secures FDA Approval for Next-Gen COVID-19 Vaccine
Moderna has achieved FDA approval for its advanced COVID-19 vaccine, paving the way for commercialization in the upcoming respiratory virus season of 2025–2026. This milestone follows the FDA’s recent introduction of a revised approval framework for COVID-19 vaccines. Additionally, the announcement coincides with HHS Secretary Robert F. Kennedy Jr.’s statement regarding the exclusion of routine […]
